Computerized Assessment for Patients With Cancer
ESRA-C_II
2 other identifiers
interventional
779
1 country
2
Brief Summary
This research study will test a new online computer program for patients, the Electronic Self-Report Assessment-Cancer (ESRA-C 2). The program allows patients to report symptoms and quality of life issues and learn information about how to deal with these experiences. The computer program is being tested to see if it can improve communications between patients and their care team and if it can improve patients' experiences during and after treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable cancer
Started Oct 2008
Longer than P75 for not_applicable cancer
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedFirst Submitted
Initial submission to the registry
February 26, 2009
CompletedFirst Posted
Study publicly available on registry
February 27, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedFebruary 1, 2018
January 1, 2018
2.7 years
February 26, 2009
January 30, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Symptom burden and quality of life 2-4 weeks post treatment
3 years
Secondary Outcomes (1)
To assess the feasibility of delivering a patient oriented, patient-controlled ESRA-C directly to patients outside clinically settings.
3 years
Study Arms (2)
Intervention
EXPERIMENTALPatient participants in the intervention arm can access educational information about self-care strategies, track and share reports of their symptoms and quality of life issues over time, and receive coaching on how to discuss these issues with their care team.
Control
NO INTERVENTIONParticipants in the control arm access the ESRA-C from home or clinic to self-assess only.
Interventions
The Electronic Self-Report Assessment-Cancer (ESRA-C) is a program allowing patients to report symptoms and quality of life issues and learn information about how to deal with these experiences.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Dana-Farber Cancer Institutelead
- Fred Hutchinson Cancer Centercollaborator
- University of Washingtoncollaborator
- National Institute of Nursing Research (NINR)collaborator
Study Sites (2)
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
University of Washington Medical Center
Seattle, Washington, 98115, United States
Related Publications (6)
Knoerl R, Hong F, Blonquist T, Berry D. Impact of Electronic Self-Assessment and Self-Care Technology on Adherence to Clinician Recommendations and Self-Management Activity for Cancer Treatment-Related Symptoms: Secondary Analysis of a Randomized Controlled Trial. JMIR Cancer. 2019 Jan 8;5(1):e11395. doi: 10.2196/11395.
PMID: 30622093DERIVEDKnoerl R, Weller E, Halpenny B, Berry D. Exploring the efficacy of an electronic symptom assessment and self-care intervention to preserve physical function in individuals receiving neurotoxic chemotherapy. BMC Cancer. 2018 Dec 4;18(1):1203. doi: 10.1186/s12885-018-5093-z.
PMID: 30514351DERIVEDSiefert ML, Bonquist TM, Berry DL, Hong F. Symptom-related emergency department visits and hospital admissions during ambulatory cancer treatment. J Community Support Oncol. 2015 May;13(5):188-94. doi: 10.12788/jcso.0134.
PMID: 27119127DERIVEDBerry DL, Blonquist TM, Patel RA, Halpenny B, McReynolds J. Exposure to a patient-centered, Web-based intervention for managing cancer symptom and quality of life issues: impact on symptom distress. J Med Internet Res. 2015 Jun 3;17(6):e136. doi: 10.2196/jmir.4190.
PMID: 26041682DERIVEDBerry DL, Hong F, Halpenny B, Partridge A, Fox E, Fann JR, Wolpin S, Lober WB, Bush N, Parvathaneni U, Amtmann D, Ford R. The electronic self report assessment and intervention for cancer: promoting patient verbal reporting of symptom and quality of life issues in a randomized controlled trial. BMC Cancer. 2014 Jul 12;14:513. doi: 10.1186/1471-2407-14-513.
PMID: 25014995DERIVEDHong F, Bosco JL, Bush N, Berry DL. Patient self-appraisal of change and minimal clinically important difference on the European organization for the research and treatment of cancer quality of life questionnaire core 30 before and during cancer therapy. BMC Cancer. 2013 Mar 28;13:165. doi: 10.1186/1471-2407-13-165.
PMID: 23537330DERIVED
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Donna L. Berry
Dana-Farber Cancer Institute
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc. Professor, Harvard Medical School; Director, The Phyllis F. Cantor Center, Research in Nursing and Patient Care Services; Affiliate Professor, University of Washington School of Nursing
Study Record Dates
First Submitted
February 26, 2009
First Posted
February 27, 2009
Study Start
October 1, 2008
Primary Completion
July 1, 2011
Study Completion
December 1, 2013
Last Updated
February 1, 2018
Record last verified: 2018-01
Data Sharing
- IPD Sharing
- Will not share